Vectura Group plc - Financial and Strategic Analysis Review
| Publication Date | June 2009 |
|---|---|
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 18 |
| ISBN Number | not applicable |
| Product Code | GMD06566 |
Buy this product or for assistance call +44 20 7060 7474
Summary
Vectura Group plc - Financial and Strategic Analysis Review
Vectura Group plc is a pulmonary drug development company, which is engaged in the development of a wide range of inhaled pharmaceuticals used for the treatment of respiratory, neurological and other diseases. Its formulation and device technologies are provided to other pharmaceutical companies on a licensing basis. Its product portfolio consists of eight marketed products and a portfolio of drugs in the clinical and pre-clinical development stage. The company is headquartered in Wiltshire, United Kingdom
Global Markets Direct's Vectura Group plc - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Vectura Group plc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
- Provides key company information for business intelligence needs.
- The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers' businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers - with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company's financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Content
- List of Tables
- List of Figures
- Key Facts
- Business Description
- Major Products and Services
- History
- SWOT Analysis
- SWOT Analysis - Overview
- Vectura Group plc - Strengths
- Vectura Group plc - Strengths - Strong Revenue Growth
- Vectura Group plc - Strengths - Marketed Products
- Vectura Group plc - Strengths - Inhalation Technologies
- Vectura Group plc - Strengths - Strong Cash Reserves
- Vectura Group plc - Strengths - Strong Liquidity Position
- Vectura Group plc - Strengths - Intellectual Property
- Vectura Group plc - Strengths - Expanding Market Share in Sector
- Vectura Group plc - Weaknesses
- Vectura Group plc - Weaknesses - Declining Operating Margin
- Vectura Group plc - Weaknesses - Low Return on Equity
- Vectura Group plc - Opportunities
- Vectura Group plc - Opportunities - Product Development Portfolio
- Vectura Group plc - Opportunities - License Partnership with Sandoz
- Vectura Group plc - Opportunities - Emerging Respiratory Market
- Vectura Group plc - Opportunities - Expansion of Manufacturing Facility
- Vectura Group plc - Threats
- Vectura Group plc - Threats - Product Liability,Negative Publicity and Insurance
- Vectura Group plc - Threats - Competition and Technological Change
- Vectura Group plc - Threats - Stringent Government Regulations
- Vectura Group plc - Threats - Industry Consolidation
- Key Competitors
- Key Employees
- Key Employee Biographies
- Company Statement
- Locations And Subsidiaries
- Locations And Subsidiaries - Head Office
- Locations And Subsidiaries - Other Locations & Subsidiaries
- Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Appendix
- Methodology
- Ratio Definitions
- About Global Markets Direct
- Contact Us
- Disclaimer
- List of Tables
- Vectura Group plc, Key Facts
- Major Products and Services
- Vectura Group plc, History
- Vectura Group plc, Key Employees
- Vectura Group plc, Key Employee Biographies
- Vectura Group plc, Other Locations
- Vectura Group plc, Ratios based on current share price
- Vectura Group plc, Annual Ratios
- Vectura Group plc, Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Vectura Group plc, Ratio Charts
Delivery Details
PDF:Delivered by email usually within 12 to 24 UK business hours.
Product features / use
| Scope | Expert Insight/Opinion | ![]() |
| Profiles | In-depth Company Insight | ![]() |
| Features | Contains SWOT Analysis | ![]() |
Related Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories












